A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease. This unexpected discovery could help doctors identify which ...

Ibcasertib is under clinical development by Shenzhen Chipscreen Biosciences and currently in Phase II for Non-Hodgkin Lymphoma.

Olaparib is under clinical development by AstraZeneca and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II drugs for Malignant Mesothelioma have a 42% phase ...

Some habits, like exercise and avoiding pollutants, may help support your lung health. If you’ve recently quit smoking, you’ve taken an important first step toward taking control of your health.

Ductal carcinoma of the prostate might be the primary diagnosis or an incidental finding mixed with acinar adenocarcinoma during pathologic examination.

Treatment for lung cancer varies according to age, type of cancer, extent of disease, tolerance to medication and patient preference. Treatment options include a combination of surgery, radiation, ...

Therefore, the application of deep learning models to segment and quantitatively predict PD-L1 expression in digital sections of Hematoxylin and eosin (H&E) stained lung squamous cell carcinoma is of ...

Although some people may consider vaping a better alternative to smoking, it can still lead to lung damage. Scientists are still investigating the effects of vaping and whether lung damage may heal.

Research has found a link between getting too much or too little sleep and an increased risk of developing lung cancer. Having lung cancer may also affect your sleep. Getting enough high quality ...

Now researchers at Dalhousie University are using an old testing method to help them learn more about how these devices affect lung function in young adults. The lung clearance index (LCI ...